203 related articles for article (PubMed ID: 27922670)
1. Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
Chen L; Wang G; Luo Y; Wang Y; Xie C; Jiang W; Xiao Y; Qian G; Wang X
Int J Oncol; 2017 Jan; 50(1):263-271. PubMed ID: 27922670
[TBL] [Abstract][Full Text] [Related]
2. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of
Hu Q; Wang G; Peng J; Qian G; Jiang W; Xie C; Xiao Y; Wang X
Biomed Res Int; 2017; 2017():3781904. PubMed ID: 29147649
[TBL] [Abstract][Full Text] [Related]
4. LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.
Jiang T; Lu X; Yang F; Wang M; Yang H; Xing N
FEBS Open Bio; 2020 Oct; 10(10):2107-2121. PubMed ID: 32865871
[TBL] [Abstract][Full Text] [Related]
5. PPARγ inhibition regulates the cell cycle, proliferation and motility of bladder cancer cells.
Cheng S; Qian K; Wang Y; Wang G; Liu X; Xiao Y; Wang X
J Cell Mol Med; 2019 May; 23(5):3724-3736. PubMed ID: 30912275
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
8. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma.
Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q
Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625
[TBL] [Abstract][Full Text] [Related]
9. Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination.
Pak Y; Glowacka WK; Bruce MC; Pham N; Rotin D
J Cell Biol; 2006 Nov; 175(4):631-45. PubMed ID: 17116753
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer.
Cheng S; Wang G; Wang Y; Cai L; Qian K; Ju L; Liu X; Xiao Y; Wang X
Clin Sci (Lond); 2019 Aug; 133(15):1745-1758. PubMed ID: 31358595
[TBL] [Abstract][Full Text] [Related]
11. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
13. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α.
Lu M; Ge Q; Wang G; Luo Y; Wang X; Jiang W; Liu X; Wu CL; Xiao Y; Wang X
Cell Death Dis; 2018 Oct; 9(10):1046. PubMed ID: 30315244
[TBL] [Abstract][Full Text] [Related]
14. Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.
Wei S; Fukuhara H; Kawada C; Kurabayashi A; Furihata M; Ogura S; Inoue K; Shuin T
Pathobiology; 2015; 82(5):224-32. PubMed ID: 26381881
[TBL] [Abstract][Full Text] [Related]
15. Collagen type VI‑α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
Piao XM; Hwang B; Jeong P; Byun YJ; Kang HW; Seo SP; Kim WT; Lee JY; Ha YS; Lee YS; Kim IY; Choi YH; Cha EJ; Moon SK; Yun SJ; Kim WJ
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982770
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.
Li C; Liu J; Zhang Q; Cui K; Ge Q; Wang C; Chen Z
Int J Oncol; 2018 Jun; 52(6):1815-1826. PubMed ID: 29620261
[TBL] [Abstract][Full Text] [Related]
17. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
[TBL] [Abstract][Full Text] [Related]
18. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein U is a potential target for gene therapy of human bladder cancer.
Wang S; Liu B; Zhang J; Sun W; Dai C; Sun W; Li Q
Oncol Rep; 2017 Aug; 38(2):735-744. PubMed ID: 28677729
[TBL] [Abstract][Full Text] [Related]
20. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
